Catalyst Wire Dossier Catalyst Wire Dossier

Topical Sirolimus 0.2%

sirolimus · Narrows Institute for Biomedical Research
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical Sirolimus 0.2%, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans [Phase 2]

See pricing